![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, October 06, 2020 11:26:15 AM
Important notes from the latest PR (other than the details on promissory note):
-EUA is submitted and waiting determination by FDA
-Company in Large negotiations with Russian partner
- Other potential distribution partnership in EU, Africa and Middle East
“The company's new GenViro!TM product designed to test for the Coronavirus Covid-19 is not yet available in the United States or Puerto Rico but Emergency Waivers have been submitted and are awaiting determination.
This is how they do it. Provide a vague reference in a PR with different terminology (emergency waiver) and then let the minions propagate the rumor. Spreads like a brush fire. berman can claim plausible deniability.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM